Dr. Kratz from UCSF gave a terrific summary on ‘Surgery for Early-Stage NSCLC’ IASLC #BestofWCLC24

Amazing session by Dr. Wakelee Heather Wakelee from Stanford on ‘Adjuvant/Neo-adjuvant Systemic Therapy’ at IASLC #BestofWCLC24

Wrapping up an amazing month at Stanford Medicine as an IASLC Lung Cancer Mentorship Award recipient under Dr. Lui Natalie Lui. Very grateful to have learnt from pioneers in lung cancer, and guidance from my mentor Jeff Yang MD FACS, without whom this would not have been possible!

Bumped into Ayush Jaiswal of PestoAI at the SF airport! It was just yesterday I was debating whether to text him, and today I find him on the escalator right in front of me! It was great to meet you Ayush!

Last week, Upstage Lung Cancer put on an incredible concert (as always) to support lung cancer awareness!! Deeply appreciative of Upstage Lung Cancer for acknowledging our work in #lungcancerscreening. Thank you so much Hildy Grossman for being such an inspiration to all of us!!

.ALCSI is proud to have worked w/ Senators Tina Smith Chuck Grassley Shelley Moore Capito Senator Dick Durbin Senator Mazie Hirono Senator Jack Reed. The Senate unanimously passed a bipartisan resolution recognizing Nov 24' as National #LCAM & supporting #lungcancerscreening for the 5th yr in a row!!

📣 On December 11th, we gained valuable insights from the CEO of Healthspan Digital Fady Hannah-Shmouni, MD FRCPC, a precision health and longevity medicine technology company dedicated to extending healthy years through advanced AI-powered software! Listen here! bit.ly/caiire-2

We are so grateful to have had physician and lung cancer patient Dr. Bryant Lin as our Distinguished Lecture speaker! Our team was truly inspired after hearing Dr. Lin’s journey, and everything he does to raise #lungcancerawareness! youtu.be/BYKeqqUFC6c?si…

Thank you to ACS National Lung Cancer Roundtable for inviting our team to #NLCRT2024! Our team shared our community outreach efforts over the past year & updates on the #PlusOneCampaign. Between presentations, members had the opportunity to connect w/ leaders to learn about & discuss #lungcancerscreening

We are excited to share that we have received 5 new proclamations from cities in Rhode Island that recognized November 2024 as #LCAM! We are grateful for the support of all these mayors in raising #lungcanceeawareness in their respective cities!

Looking ahead to 2025, we’re committed to growing ALCSI nationwide! Interested in starting a chapter in your community? We’re here to help every step of the way. DM us to get started and join the fight against lung cancer! #LungCancerAwareness #ALCSI

Start an ALCSI chapter TODAY!! ALCSI students have the opportunity to connect with #lungcancer experts and advocates around the nation! DM us to get started and join the fight against lung cancer!

Check out the latest episode from the #ThinkingThoracic podcast!! At #STS2025, Erin Gillaspie, Hari Keshava, Jane Yanagawa & I talk about wedge vs segment and considerations for sublobar resection for #lungcancer: thinkingthoracic.podbean.com/e/leading-scie…

Dr. Valerie Rusch presents, at #GTSC2025, the most recent changes to the IASLC 9th edition staging system. For lung: No changes to T category. Changes to N: N2 split into N2a & N2b. Changes in M categories (see slide). For the 10th edition: need more cases from North America.

April's Annals of Thoracic Surgery issue will feature a study led by Alexandra Potter on #lungcancerscreening eligibility in the Boston Lung Cancer Study: authors.elsevier.com/a/1koSaovKl3dU Only 46% of patients with #lungcancer were eligible to get screened under current USPSTF guidelines.

Screening for breast cancer and colorectal cancer among individuals eligible for lung cancer screening was nearly 4-fold higher than rates of screening for lung cancer. ja.ma/3QZp2zd

Listen to a discussion of "Preventive Health Care Among Adults Eligible for Lung Cancer Screening." Hosted on AMA Ed Hub™. ja.ma/4jjBjuG

Our study in JAMA found that most people eligible for #lungcancerscreening (LCS) are already getting screened for breast & colon cancers. LCS eligible adults ARE receptive to cancer screening. They are NOT “hard to reach,” they are “hardly reached.”

Dr. Chi-Fu Jeffrey Yang’s team (@chifujeffyang) from the Division of Thoracic Surgery just published a landmark study in JAMA: use of breast & colorectal cancer screening was nearly 4-fold higher than use of lung cancer screening among eligible individuals shorturl.at/1vvPV